NCT06271226

Brief Summary

The aim of this experimental study is to determine the effect of acupressure applied to intensive care patients on pain and physiological parameters (blood pressure, heart rate, respiration and oxygen saturation). The main questions that the study aims to answer are: Acupressure applied to intensive care patients has no effect on pain. Acupressure applied to intensive care patients has an effect on pain. Acupressure applied to intensive care patients has no effect on physiological parameters. Acupressure applied to intensive care patients has an effect on physiological parameters. Participants will be included in the study after obtaining consent from patients who were treated in the intensive care unit, who scored 9 and above on the glaskow coma scale by evaluating their consciousness status, and had pain after evaluating their pain.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 20, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 19, 2023

Completed
5 months until next milestone

First Posted

Study publicly available on registry

February 21, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

February 21, 2024

Status Verified

February 1, 2024

Enrollment Period

1.3 years

First QC Date

September 19, 2023

Last Update Submit

February 14, 2024

Conditions

Keywords

acupressurecritical care nursingcomplementary therapiespain management

Outcome Measures

Primary Outcomes (3)

  • neurological evaluation

    It will be evaluated using the Glaskow Coma scale. With the Glaskow Coma scale, three main functions of the patients, namely eye opening, verbal and motor, are evaluated and scored. Patients' eye opening is scored as 1-4 points, verbal response as 1-5 points, and motor response as 1-6, and the level of consciousness is determined by the total score. As the score of the scale increases, the risk of mortality decreases and the level of awareness increases.

    it is applied to the participants before the start of the study

  • evaluation of pain

    Visual Analog Scale is a one-dimensional measurement tool used to evaluate the pain perceived by the person. The scale is 0-10 cm or 0-100 mm, with no pain (0) at one end, and the worst possible pain (10) at the other end.In the evaluation of VAS, 0 cm = no pain, 0.5-3 cm = mild pain, 3.5-6.5 cm = moderate pain, 7-10 cm = severe pain.

    The pain scores of the patients included in the study will be recorded twice a day (morning and evening).

  • evaluation of physiological parameters

    the physiological parameter was recorded with the registration form.This form includes the patients' blood pressure, heart rate, respiration and SPO2 values.

    The data of the patients included in the study will be recorded twice a day (morning and evening).

Secondary Outcomes (1)

  • evaluation of physiological parameters

    The data of the patients included in the study will be recorded twice a day (morning and evening) for 2 days.

Study Arms (3)

acupressure

EXPERIMENTAL

Information about the pre-procedure intervention will be given. Before acupressure, the participant's physiological parameters and pain score will be recorded, then the hands will be washed in preparation for the acupuncture application and the patient will be placed in a supine or semi-sitting position. Compression points are HT7, P6, P7, Li4, Lv3 points and the location will be determined by the patient's own finger size. Before pressing, a relaxing-relaxing patting motion will be applied to these points for 10 seconds. Then, 1.5 minutes, 5 seconds of thumb pressure and 1 second of free pressure to each point will be applied to each point twice a day (morning and evening). In total it will take 15 minutes to press all the dots. At the end of the application and 15 minutes and 30 minutes after the application, the participant's physiological parameter data and pain score will be re-evaluated and recorded. These data will be recorded twice a day (morning and evening) for 2 days.

Other: acupressure

plasebo acupressure

ACTIVE COMPARATOR

In the placebo group, the preparations and forms applied to the experimental group will be applied in the same way, but in accordance with the literature, an area 1.5 cm away from the acupressure point that has no connection with the acupressure point will be selected and the application will be made in the form of light touch.

Other: placebo acupressure

control group

OTHER

During the study, pain and physiological parameters will be monitored and recorded twice a day (morning and evening) for 2 days, without any application (other than the routine treatment given by the physician).

Other: control group

Interventions

With acupressure, massage or pressure is applied to certain points on the body with fingers, hands or palms. The pressed points are the points on the skin that are sensitive to bioelectrical impulses and can easily transmit them.

Also known as: finger pressure
acupressure

n the placebo group, the preparations and forms applied to the experimental group will be applied in the same way, but in accordance with the literature, an area 1.5 cm away from the acupressure point that has no connection with the acupressure point will be selected and the application will be made in the form of light touch

Also known as: sham acupressure
plasebo acupressure

During the study, pain and physiological parameters will be monitored and recorded twice a day (morning and evening) for 2 days, without any application (other than the routine treatment given by the physician).

Also known as: follow up
control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being 18 years or older
  • Volunteering to participate in the research.
  • Getting a score of 9 and above on the Glasgow Coma Scale and being able to communicate meaningfully,
  • Oxygen saturation of 85 and above
  • Mean arterial pressure of 65 mmHg and above

You may not qualify if:

  • Diagnosis of suspected acute stroke bleeding
  • Taking antihypertensive and beta-blocker drugs the start of the study
  • Receiving sedation (dormicum, propofol, brunette)
  • Presence of ulcers, bilateral paralysis, necrotic tissue and signs of infection (fever, redness, discharge, temperature) at the pressure points
  • Situations that will cause the participant to leave the study (death, transfer to another unit, discharge or unwillingness to continue working)
  • Receiving inotropic therapy (dopamine, steradine, etc.)
  • Absence of analgesic therapy in routine treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Giresun Eğitim Araştırma Hastanesi

Giresun, 28000, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

PainAgnosia

Interventions

AcupressureControl Groups

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

Therapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitationEpidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • emine yaman lezki

    Ondokuz Mayıs universty

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
participant and statistical analysis expert is blind.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Since there will be variability in patient admissions to intensive care units, block randomization will be used. Three different groups will be coded with different letters (A,B,C) and blocks will be created. Then randomization will be performed by assigning random numbers on the computer. The letters determined in the randomization will be written in closed envelopes and stored, and the randomization process will be carried out by an independent researcher. After the patient who meets the inclusion criteria is identified, the independent researcher will be contacted to find out which group the patient is in.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
expert nurse

Study Record Dates

First Submitted

September 19, 2023

First Posted

February 21, 2024

Study Start

March 20, 2023

Primary Completion

June 30, 2024

Study Completion

December 31, 2024

Last Updated

February 21, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will share

study results can be shared at the end of the study

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
study results can be shared at the end of the study
Access Criteria
when the study is concluded, the data can be accessed within the limits determined by the principal investigator.

Locations